FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135455909> ?p ?o ?g. }

• W2135455909 endingPage "576" @default.
• W2135455909 startingPage "569" @default.
• W2135455909 abstract "Information regarding treatment of post-transplant lymphoproliferative disease (PTLD) beyond reduction in immunosuppression (RI) is limited. We retrospectively evaluated patients receiving rituximab and/or chemotherapy for PTLD for response, time to treatment failure (TTF) and overall survival (OS). Thirty-five patients met inclusion criteria. Twenty-two underwent rituximab treatment, with overall response rate (ORR) 68%. Median TTF was not reached at 19 months and estimated OS was 31 months. In univariable analysis, Epstein-Barr virus (EBV) positivity predicted response and TTF. LDH elevation predicted shorter OS. No patient died of rituximab toxicity and all patients who progressed underwent further treatment with chemotherapy. Twenty-three patients received chemotherapy. ORR was 74%, median TTF was 10.5 months and estimated OS was 42 months. Prognostic factors for response included stage, LDH and allograft involvement by tumor. These factors and lack of complete response (CR) predicted poor survival. Twenty-six percent of the patients receiving chemotherapy died of toxicity. Rituximab and chemotherapy are effective in patients with PTLD who fail or do not tolerate RI. While rituximab is well tolerated, toxicity of chemotherapy is marked. PTLD patients requiring therapy beyond RI should be considered for rituximab, especially with EBV-positive disease. Chemotherapy should be reserved for patients who fail rituximab, have EBV-negative tumors or need a rapid response." @default.
• W2135455909 created "2016-06-24" @default.
• W2135455909 creator A5014407031 @default.
• W2135455909 creator A5023701084 @default.
• W2135455909 creator A5025991750 @default.
• W2135455909 creator A5029801761 @default.
• W2135455909 creator A5045120185 @default.
• W2135455909 creator A5049220182 @default.
• W2135455909 creator A5055765840 @default.
• W2135455909 creator A5067318560 @default.
• W2135455909 creator A5080126178 @default.
• W2135455909 creator A5080630441 @default.
• W2135455909 creator A5088286702 @default.
• W2135455909 date "2006-03-01" @default.
• W2135455909 modified "2023-10-16" @default.
• W2135455909 title "Treatment of PTLD with Rituximab or Chemotherapy" @default.
• W2135455909 cites W126717145 @default.
• W2135455909 cites W1901176265 @default.
• W2135455909 cites W1911976151 @default.
• W2135455909 cites W1912693401 @default.
• W2135455909 cites W1933173616 @default.
• W2135455909 cites W1933649159 @default.
• W2135455909 cites W1966831995 @default.
• W2135455909 cites W1971823915 @default.
• W2135455909 cites W2015278968 @default.
• W2135455909 cites W2026689623 @default.
• W2135455909 cites W2050690193 @default.
• W2135455909 cites W2056549675 @default.
• W2135455909 cites W2075396034 @default.
• W2135455909 cites W2097787479 @default.
• W2135455909 cites W2117964879 @default.
• W2135455909 cites W2118511629 @default.
• W2135455909 cites W2151139118 @default.
• W2135455909 cites W2324553589 @default.
• W2135455909 cites W2330963720 @default.
• W2135455909 cites W2628252608 @default.
• W2135455909 cites W4253113947 @default.
• W2135455909 cites W51893192 @default.
• W2135455909 doi "https://doi.org/10.1111/j.1600-6143.2005.01211.x" @default.
• W2135455909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16468968" @default.
• W2135455909 hasPublicationYear "2006" @default.
• W2135455909 type Work @default.
• W2135455909 sameAs 2135455909 @default.
• W2135455909 citedByCount "228" @default.
• W2135455909 countsByYear W21354559092012 @default.
• W2135455909 countsByYear W21354559092013 @default.
• W2135455909 countsByYear W21354559092014 @default.
• W2135455909 countsByYear W21354559092015 @default.
• W2135455909 countsByYear W21354559092016 @default.
• W2135455909 countsByYear W21354559092017 @default.
• W2135455909 countsByYear W21354559092018 @default.
• W2135455909 countsByYear W21354559092019 @default.
• W2135455909 countsByYear W21354559092020 @default.
• W2135455909 countsByYear W21354559092021 @default.
• W2135455909 countsByYear W21354559092022 @default.
• W2135455909 countsByYear W21354559092023 @default.
• W2135455909 crossrefType "journal-article" @default.
• W2135455909 hasAuthorship W2135455909A5014407031 @default.
• W2135455909 hasAuthorship W2135455909A5023701084 @default.
• W2135455909 hasAuthorship W2135455909A5025991750 @default.
• W2135455909 hasAuthorship W2135455909A5029801761 @default.
• W2135455909 hasAuthorship W2135455909A5045120185 @default.
• W2135455909 hasAuthorship W2135455909A5049220182 @default.
• W2135455909 hasAuthorship W2135455909A5055765840 @default.
• W2135455909 hasAuthorship W2135455909A5067318560 @default.
• W2135455909 hasAuthorship W2135455909A5080126178 @default.
• W2135455909 hasAuthorship W2135455909A5080630441 @default.
• W2135455909 hasAuthorship W2135455909A5088286702 @default.
• W2135455909 hasBestOaLocation W21354559091 @default.
• W2135455909 hasConcept C126322002 @default.
• W2135455909 hasConcept C141071460 @default.
• W2135455909 hasConcept C143998085 @default.
• W2135455909 hasConcept C2776694085 @default.
• W2135455909 hasConcept C2779338263 @default.
• W2135455909 hasConcept C2780252810 @default.
• W2135455909 hasConcept C2780653079 @default.
• W2135455909 hasConcept C71924100 @default.
• W2135455909 hasConcept C90924648 @default.
• W2135455909 hasConceptScore W2135455909C126322002 @default.
• W2135455909 hasConceptScore W2135455909C141071460 @default.
• W2135455909 hasConceptScore W2135455909C143998085 @default.
• W2135455909 hasConceptScore W2135455909C2776694085 @default.
• W2135455909 hasConceptScore W2135455909C2779338263 @default.
• W2135455909 hasConceptScore W2135455909C2780252810 @default.
• W2135455909 hasConceptScore W2135455909C2780653079 @default.
• W2135455909 hasConceptScore W2135455909C71924100 @default.
• W2135455909 hasConceptScore W2135455909C90924648 @default.
• W2135455909 hasIssue "3" @default.
• W2135455909 hasLocation W21354559091 @default.
• W2135455909 hasLocation W21354559092 @default.
• W2135455909 hasOpenAccess W2135455909 @default.
• W2135455909 hasPrimaryLocation W21354559091 @default.
• W2135455909 hasRelatedWork W148461728 @default.
• W2135455909 hasRelatedWork W2002120878 @default.
• W2135455909 hasRelatedWork W2020124248 @default.
• W2135455909 hasRelatedWork W2047967234 @default.
• W2135455909 hasRelatedWork W2070268111 @default.
• W2135455909 hasRelatedWork W2080180985 @default.

• next